Efficacy of icotinib in advanced lung squamous cell carcinoma

Efficacy of icotinib in advanced lung squamous cell carcinoma

Abstract Background There are controversial data supporting the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with advanced lung squamous cell carcinoma (SCC). In this study, the efficacy of icotinib in unselected and EGFR‐mutated patients with lun...

Full description

Bibliographic Details
Main Authors: Shuai Liang, Yan Xu, Fenlai Tan, Lieming Ding, Yongbin Ma, Mengzhao Wang
Format: Article
Language:English
Published: Wiley 2018-09-01
Series:Cancer Medicine
Subjects:
adenocarcinoma
EGFR
EGFR‐TKIs
icotinib
squamous cell carcinoma
Online Access:https://doi.org/10.1002/cam4.1736

Internet

https://doi.org/10.1002/cam4.1736

Similar Items